Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

Rasmussen's encephalitis is a rare chronic neurological disorder, characterised by
unilateral inflammation of the cerebral cortex, drug-resistant epilepsy, and progressive …

Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading
to unilateral hemispheric atrophy, associated progressive neurological dysfunction and …

Human immunoglobulin prepared for intravenous administration (IGIV) has a number of
important uses in the treatment of disease. Some of these are in diseases for which …

Despite high‐dose intravenous immunoglobulin (IVIG) is widely used in treatment of a
number of immune‐mediated neurological diseases, the consensus on its optimal use is …

ContextIntravenous immunoglobulin (IVIG) enhances immune homeostasis by modulating
expression and function of Fc receptors, interfering with activation of complement and …

Canada's per capita use of intravenous immune globulin (IVIG) grew by approximately
115% between 1998 and 2006, making Canada one of the world's highest per capita users …

The authors investigated immunomodulatory treatments in 15 patients with Rasmussen
encephalitis (RE)(14 with childhood and one with adolescent onset RE). Positive time …

Rasmussen's encephalitis (RE) is a rare, progressive, chronic encephalitis characterised by
drug-resistant epilepsy, progressive hemiparesis and mental impairment. It typically involves …

Glutamate is the major excitatory neurotransmitter of the Central Nervous System (CNS),
and it is crucially needed for numerous key neuronal functions. Yet, excess glutamate …